Starting Wegovy, Ozempic or Mounjaro is a significant step — and if you take other medications, it is natural to wonder whether they still work as expected. The answer is nuanced: GLP-1 agonists can change the way your body absorbs oral medications, which matters more for some drugs than others. Understanding which interactions are most important helps you have an informed conversation with your doctor.
How does the interaction happen?
The primary mechanism is not what most people think of as a "drug interaction." GLP-1 agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) delay gastric emptying — the process by which food and medications pass from the stomach into the small intestine, where absorption takes place. Studies show this delay is in the range of 20–35%. When gastric emptying slows, any oral medication taken at the same time will take longer to reach peak concentration in the bloodstream and may be absorbed at a different rate.
This is what pharmacologists call a pharmacokinetic interaction affecting absorption — it is distinct from the enzyme or transporter-based interactions you may have read about with other medications. The good news is that for most drugs, the overall amount absorbed (the total area under the curve) changes very little. What changes more is the peak concentration and the time to reach it. For most medications this is clinically unimportant — but for a handful of drugs with narrow therapeutic windows, it matters a great deal.
Oral contraceptives — use backup protection
The FDA prescribing information for Wegovy (semaglutide 2.4 mg) specifically flags oral contraceptives as a known concern. In a dedicated interaction study, the Cmax of an oral contraceptive containing ethinylestradiol and levonorgestrel was reduced by approximately 20% when taken with semaglutide. While this does not mean the pill stops working entirely, it raises the theoretical risk of reduced efficacy.
The FDA recommendation is clear: use an additional non-hormonal backup method of contraception for 4 weeks when starting semaglutide and for 4 weeks after each dose escalation. Non-oral methods — the contraceptive patch, vaginal ring, hormonal IUD or injection — are unaffected by delayed gastric emptying and do not require backup protection. If you are unsure which method is right for you, speak to your doctor or gynaecologist.
Levothyroxine (thyroid medication) — timing matters
Levothyroxine, taken by millions of people for an underactive thyroid, is one of the most absorption-sensitive medications that exists. It is typically taken on an empty stomach first thing in the morning, 30–60 minutes before food, precisely because food, coffee and other medications can significantly impair its absorption.
On a GLP-1 injection day, slowed gastric emptying may extend the absorption window unpredictably. The practical advice is to take levothyroxine at least 4 hours before any meal on injection days, and to have your TSH levels checked more frequently in the first months of GLP-1 treatment. A dose that was previously well-calibrated may need adjustment once your gastric emptying pattern changes.
Sulfonylureas and insulin — risk of low blood sugar
If you take insulin or a sulfonylurea (such as glipizide, glyburide or glimepiride) for type 2 diabetes, combining them with a GLP-1 agonist increases the risk of hypoglycaemia — dangerously low blood sugar. GLP-1 agonists lower blood glucose on their own through multiple mechanisms; adding a sulfonylurea or insulin on top can push glucose too low.
This is one of the best-documented interactions in the prescribing information for all GLP-1 medications. Your doctor will often reduce the dose of the sulfonylurea or insulin when you start GLP-1 therapy. Monitor your blood glucose more closely during the adjustment period, and know the signs of hypoglycaemia: shakiness, sweating, confusion and rapid heartbeat.
Cyclosporine — monitor blood levels
Cyclosporine, an immunosuppressant used after organ transplantation and for certain autoimmune conditions, has a narrow therapeutic range — small changes in absorption can have serious consequences. The FDA label for semaglutide warns that it may reduce cyclosporine absorption. If you take cyclosporine and are prescribed a GLP-1 agonist, your doctor should monitor your cyclosporine blood levels carefully, especially at treatment initiation and after each dose escalation. Separating the doses in time may help, but always follow your specialist's advice.
Warfarin and anticoagulants — watch your INR
Warfarin and related vitamin K antagonists require regular INR monitoring to ensure your blood remains in the safe clotting range. When starting GLP-1 therapy, two things can shift your INR: the associated weight loss and reduced food intake may change how much vitamin K you consume through diet, and nausea or vomiting in the first weeks can reduce food intake further. More frequent INR checks — especially in the first 2–3 months of GLP-1 therapy or after each dose escalation — are strongly recommended. Let your anticoagulation clinic know you are starting or adjusting your GLP-1 dose.
Alcohol — an indirect risk worth knowing
Alcohol is not a direct pharmacological interaction with GLP-1 agonists, but it is worth discussing with your doctor. Alcohol can lower blood glucose unpredictably, particularly in people also taking insulin or sulfonylureas, creating a heightened risk of hypoglycaemia. Additionally, alcohol tends to worsen nausea — one of the most common side effects of GLP-1 medications — and may increase the likelihood of vomiting. If you drink alcohol, keeping it moderate and always eating food alongside it is advisable.
The general rule — tell everyone what you take
The interactions listed here are manageable. They are not reasons to avoid GLP-1 medications — for most people, the benefits far outweigh these considerations. But they do require awareness and, in some cases, proactive adjustment.
The most important step you can take is to give your doctor and pharmacist a complete list of everything you take: prescription medications, over-the-counter products, vitamins, herbal supplements and any other regular medications. This allows them to identify any drugs that need closer monitoring, adjust doses proactively, or recommend timing strategies such as taking medications at different times of day. Starting GLP-1 therapy is an excellent opportunity for a comprehensive medication review.
Medical disclaimer
This article is for informational purposes only and does not replace advice from your doctor or pharmacist. Always consult your healthcare provider before making any changes to your medication routine.